Protocol BMN 111-201; A Phase 2, Open-label, Sequential Cohort Dose-escalation Study of BMN 111 in Children with Achondroplasia

Project: Research project

Project Details

StatusFinished
Effective start/end date3/22/133/23/15

Funding

  • BioMarin Pharmaceutical Inc.